Atlas Trials

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Clinical trial NCT04874428 · RECRUITING

Trial details

NCT number
NCT04874428
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2021-05-19
Primary completion
2026-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.